Aquestive Therapeutics Inc
NASDAQ:AQST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aquestive Therapeutics Inc
NASDAQ:AQST
|
US |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
DUS:MOH
|
FR |
|
F
|
Fractal Gaming Group AB
F:5HS
|
SE |
|
KISCO Corp
KRX:104700
|
KR |
|
S
|
SMX (Security Matters) PLC
NASDAQ:SMX
|
IE |
|
D
|
Dalrymple Bay Infrastructure Ltd
ASX:DBI
|
AU |
|
Cigniti Technologies Ltd
NSE:CIGNITITEC
|
IN |
|
Ufuk Yatirim Yonetim ve Gayrimenkul AS
IST:UFUK.E
|
TR |
|
T
|
Tupperware Brands Corp
SWB:TUP
|
US |
|
Damstra Holdings Ltd
ASX:DTC
|
AU |
|
EO2 SA
PAR:ALEO2
|
FR |
|
Adisyn Ltd
ASX:AI1
|
AU |
|
Ecora Resources PLC
TSX:ECOR
|
UK |
Wall Street
Price Targets
AQST Price Targets Summary
Aquestive Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AQST is 9.07 USD with a low forecast of 6.06 USD and a high forecast of 11.55 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AQST's stock price target?
Price Target
9.07
USD
According to Wall Street analysts, the average 1-year price target for AQST is 9.07 USD with a low forecast of 6.06 USD and a high forecast of 11.55 USD.
What is Aquestive Therapeutics Inc's Revenue forecast?
Projected CAGR
36%
For the last 8 years the compound annual growth rate for Aquestive Therapeutics Inc's revenue is -5%. The projected CAGR for the next 3 years is 36%.
